Fluorescence Imaging of the Parathyroid Glands of Children

Status Recruiting

Clinical Trial Summary

The aim of this study is to develop a standardized and user-independent imaging workflow model for autofluorescence and quantified fluorescence angiography with Indocyanine Green (ICG) of the parathyroid glands of children. For this purpose, all pediatric patients will undergo thyroid surgery with the use of autofluorescence and quantified ICG-fluorescence. This study could be the first step in reducing the rate of postoperative hypocalcemia in children, by using fluorescence angiography during pediatric thyroid surgery.

Clinical Trial Description

Background: Children with thyroid cancer have excellent survival rates. However, postoperative hypocalcemia, due to inadvertent excision of the parathyroid glands or damage to their vasculature during thyroid surgery, is a severe complication which occurs in 24% - 67% of the children with thyroid cancer and causes lifelong reduced quality of life and increased morbidity rates. In adults, intraoperative identification of the parathyroid glands with autofluorescence and assessment of their perfusion using quantified ICG-fluorescence angiography has shown to reduce postoperative hypocalcemia. However, in children no studies regarding quantified fluorescence of the parathyroid glands have been conducted. There is a clear need for surgical techniques to identify and preserve the parathyroid glands during thyroid surgery in children. Therefore, the aim of this study is to develop a standardized imaging workflow model for autofluorescence and quantified ICG-angiography of the parathyroid glands in children. This workflow model can be the first step in reducing the rate of postoperative hypocalcemia in children. Study design: This will be a prospective, observational, multicenter, feasibility study. The aim is to generate the patterns of intraoperative autofluorescence and quantified ICG-fluorescence angiography of the parathyroid glands in children, resulting in a user-independent, standardized imaging workflow model for autofluorescence and quantified ICG-angiography of the parathyroid glands of children. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05917067
Study type	Observational
Source	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact	Daniël van de Berg, MD
Phone	+31651001594
Email	d.j.vandeberg@amsterdamumc.nl
Status	Recruiting
Phase
Start date	September 1, 2023
Completion date	October 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05975866` - The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato	N/A
Terminated	`NCT04589884` - Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
Completed	`NCT00569920` - Nausea and Pain Prophylaxis During Thyroid Surgery	N/A
Completed	`NCT04704349` - Latest Imaging SPECT System Evaluation Phase 1	N/A
Recruiting	`NCT05430139` - Dried Blood Spot Testing for At Home Health
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Recruiting	`NCT06112340` - A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)	Phase 2/Phase 3
Recruiting	`NCT05678374` - Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Not yet recruiting	`NCT04094493` - Vit D Role in Post Thyroidectomy Hypocalcemia	Early Phase 1
Completed	`NCT03157466` - Respiratory Muscle Function After Thyroid Hormone Replacement Therapy in Nonthyroidal Illness Syndrome
Completed	`NCT04542278` - Preoperative Steroids in Autoimmune Thyroid Disease	Phase 4
Completed	`NCT04425512` - Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy	N/A
Recruiting	`NCT05510609` - Three-dimensional Ultrasonography Thyroid Volume Measurement.	N/A
Recruiting	`NCT05412680` - Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)	N/A
Completed	`NCT06227819` - BVA-200 vs BVA-100 Validation Study
Completed	`NCT00150033` - Health-Related Quality of Life for Thyroid Patients	Phase 2
Active, not recruiting	`NCT04351945` - Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
Enrolling by invitation	`NCT04411290` - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Completed	`NCT04873531` - Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Fluorescence Imaging of the Parathyroid Glands of Children — FLUOPATCH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms